Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial
Michel Azizi(Inserm), J.M. Bartoli(Hôpital de la Timone), Aurélien Lorthioir(Assistance Publique – Hôpitaux de Paris), Jean-Yves Pagny(Apple (Israel)), Caroline Dourmap-Collas(Inserm), Marc Sapoval(Délégation Paris 5), M. Claudon(Centre Hospitalier Régional et Universitaire de Nancy), Marco Midulla(Lille’s Cardiology Hospital), Olivier Rouvière(Université Claude Bernard Lyon 1), Émile Ferrari(Johnson University), Patrick Rossignol(Inserm), Jean Ribstein, Philippe Cluzel(Harvard University), Dieter Rosenbaum(Sorbonne Université), Pierre‐Yves Courand(Université Claude Bernard Lyon 1), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Jean‐Pierre Fauvel(Hôpital de la Croix-Rousse), Vincent Jullien(Centre National de la Recherche Scientifique), Hervé Trillaud(Hôpital Saint-André), Jean‐Jacques Mourad(Institut Hospitalier Franco Britannique), Matthieu Monge(Délégation Paris 5), Raphaël Dauphin(Hôpital de la Croix-Rousse), Philippe Gosse(Inserm), B Chamontin(Inserm), Idir Hamdidouche(Inserm), N. Grenier(Hôpital Saint-André), Xavier Girerd(Sorbonne Université), G. Claisse(Lille’s Cardiology Hospital), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Pascal Delsart(Inserm), Batric Popovic(Centre Hospitalier Régional et Universitaire de Nancy), Gilles Châtellier(Hôpital Saint Joseph), Laurence Amar(Unit of Functional and Adaptive Biology), Héléna Pereira(Inserm), Pierre Lantelme(Inserm), Claire Mounier‐Véhier(Inserm), Thierry Denolle(Inserm), D Herpin(Centre Jean Bernard), Guillaume Bobrie(Assistance Publique – Hôpitaux de Paris), Frédéric Thony(Centre Hospitalier Universitaire de Grenoble), François Paillard(Centre Hospitalier Universitaire de Rennes), Pierre‐Francois Plouin(Inserm), Y. Lebras(Hôpital Saint-André), D. Alison, Olivier Ormezzano(Inserm), A. Larralde(Centre Hospitalier Universitaire de Rennes), J.F. Heautot(Centre Hospitalier Universitaire de Rennes), Antoine Crémer(Hôpital Saint-André), J.-P. Baguet(Université Grenoble Alpes), B. Vaı̈sse(Inserm)
Cited by 154
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k